An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD
NCT07670702
·
clinicaltrials.gov ↗
PHASE3
Phase
ENROLLING_BY_INVITATION
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Post Traumatic Stress Disorder
Interventions
DRUG:
TSND-201
Sponsor
Transcend Therapeutics